Healthcare

ESTEVE CDMO strengthens its global manufacturing footprint with a major investment and new site in China

SHAOXING, China, Oct. 21, 2026, 06:08 GMT-04

ESTEVE

Read full article →

Arctic Therapeutics closes oversubscribed US$21.5 million financing

REYKJAVIK, Iceland AND PHILADELPHIA, October 21, 2026, 04:25 GMT-04

Arctic-Therapeutics

Read full article →

St George's and Epsom hospitals turn to MazeMap to improve the patient experience

TRONDHEIM, Norway, Oct. 21, 2026, 04:21 GMT-04

MazeMap-AS

Read full article →

CSL appoints Deborah Waterhouse as CEO & Managing Director

MELBOURNE, Australia, Oct. 21, 2026, 04:02 GMT-04

CSL

Read full article →

Daewoong Pharmaceutical Hosts First NABOTA Master Class in Latin America to Accelerate Regional Expansion

BUENOS AIRES, Argentina and SEOUL, South Korea, Oct. 21, 2026, 00:00 GMT-04

Daewoong-Pharmaceutic

Read full article →

Urinalysis Market to Reach US$ 5.9 Bn by 2031, Growing at 7% CAGR as Automation and Kidney Disease Screening Expand: Wissen Research

SHERIDAN, Wyo., Oct. 20, 2026, 11:00 GMT-04

Wissen-Research-LLC

Read full article →

Severe Hypertriglyceridemia Market Set for Growth During the Forecast Period (2026-2036) Following Approval of Ionis' TRYNGOLZA and Emergence of Novel Therapies | DelveInsight

LAS VEGAS, Oct. 20, 2026, 10:31 GMT-04

DelveInsight-Business

Read full article →

Lipid Nanoparticles Market worth $395.0 million by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 20, 2026, 10:30 GMT-04

MarketsandMarkets

Read full article →

Brainomix Multicenter Study Demonstrates Potential of Quantitative CT for Earlier Detection of Progressive Pulmonary Fibrosis (PPF)

OXFORD, England and CHICAGO, Oct. 20, 2026, 10:03 GMT-04

Brainomix

Read full article →

Patronus Biotech Receives Ethical Approval to Begin First-in-Human Phase 1 Trial of Three Multi-Stage Vaccines Against Malaria in Australia

GUANGZHOU, China, Oct. 20, 2026, 08:49 GMT-04

Patronus-Biotech

Read full article →

CAS collaborates with Microsoft to enable faster innovation in pharmaceutical, life sciences, and chemical industries

COLUMBUS, Ohio, Oct. 20, 2026, 08:00 GMT-04

CAS

Read full article →

Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain

AACHEN, Germany, Oct. 20, 2026, 05:12 GMT-04

Grunenthal-Group

Read full article →

Hengrui Pharma Previews ESMO Congress 2026 with 64 Research Findings Across Its Innovative Oncology Portfolio

SHANGHAI, Oct. 20, 2026, 04:07 GMT-04

Hengrui-Pharma

Read full article →

New Innovative Molecular Technology Combination "LAMP + CRISPR" as CE-IVD

MUNICH, Oct. 20, 2026, 02:10 GMT-04

AmplexDiagnostics

Read full article →

Abbott's Cologuard Plus® receives CE Mark for colorectal cancer screening in Europe

ABBOTT PARK, Ill.,, Oct. 20, 2026, 02:00 GMT-04

Abbott

Read full article →

L-Nutra Health opens its metabolic health programme to UK clinics and practices

LONDON, Oct. 20, 2026, 02:00 GMT-04

L-Nutra-Inc

Read full article →

Frost & Sullivan awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership

SAN ANTONIO, Oct. 20, 2026, 20:00 GMT-04

Frost-Sullivan

Read full article →

Tumor Ablation Market Set to Surge to US$ 1.8 Billion by 2031, Growing at 11.6% CAGR: Wissen Research

SHERIDAN, Wyo., Oct. 19, 2026, 17:01 GMT-04

Wissen-Research-LLC

Read full article →

LBT Unveils New 30 MeV Medical Cyclotron Platform at EANM 2026

VIENNA, Oct. 19, 2026, 16:31 GMT-04

Longevous-Beamtech

Read full article →

Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026

DUBLIN, Oct. 19, 2026, 16:15 GMT-04

Jazz-Pharmaceuticals

Read full article →